M Earleywine

Datos Biográficos

ID50476
NOMBREM Earleywine
NOMBRESM
APELLIDOEarleywine
FIRMAEARLEYWINE M
AFILIACIONESUniversity at Albany, State University of New York
ORCID0000-0002-6870-0623
VERIFICADOSí
TOTAL DE OBRAS59
TOTAL DE CITAS87
TOTAL COMO AUTOR59
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2000
AÑO MÁS RECIENTE DE PUBLICACIÓN2026
ÍNDICE H4

  • Intention-Setting Among Recreational Psychedelic Users

    Francis Low, M EarleywineARTICLEJournal of Psychoactive Drugs2026

    Limited research suggests that distinct intentions covary with acute experiences and subsequent outcomes. Nevertheless, data on the types of intentions set by users remain scarce, and their effects lack clarity. This study uses a retrospective, mixed-methods, cross-sectional approach to investigate intention-setting among psychedelic users. We establish a taxonomy of intentions in naturalistic use and examine how domain-specific intentions correl…

  • Perceptions of Psilocybin-Assisted Psychotherapy and Standard Interventions for Nicotine Cessation

    Philip Kamilar-Britt, Achille Bonito Oliva et al.ARTICLEJournal of Psychoactive Drugs2026

    Nicotine dependence remains a leading cause of preventable mortality worldwide. Pharmacotherapy and behavioral interventions offer modest efficacy with limited long-term success. Psilocybin-assisted psychotherapy (PAP) is an emerging approach to nicotine cessation with a growing evidence base. As PAP research expands, understanding how nicotine users' attitudes shape treatment engagement becomes critical. We surveyed daily nicotine users ( N = 53…

  • Variability in undergraduate academic stress

    Open AccessTeresa Mejia, Elana B Gordis et al.ARTICLECurrent Psychology2025

  • Questions and Concerns About MDMA-Assisted Therapy (MDMA-AT) in Veterans with PTSD Symptoms

    M Earleywine, Caitlin Holley et al.ARTICLEJournal of Psychoactive Drugs2025

    MDMA-assisted therapy (MDMA-AT) for post-traumatic stress disorder (PTSD) shows promise, but attitudes and beliefs about this treatment, especially in symptomatic veterans, remain poorly understood. We sought to explore relevant attitudes in veterans receiving healthcare from Veterans Affairs as a step toward designing relevant surveys or psychoeducation materials for future work. We employed a story completion paradigm designed to sidestep aspec…

  • Examining Volunteer Bias in Psychedelic Research

    Samantha G Gomez, Francis Low et al.ARTICLEJournal of Psychoactive Drugs2025

    Since its resurgence, psychedelic research has garnered considerable attention, especially in mental health. Preliminary findings have indicated positive results regarding psychedelic-assisted psychotherapy. Despite promising findings, various researchers have voiced concerns regarding psychedelic research and its potential for volunteer bias. Participants willing to participate in clinical trials, for example, might differ dramatically from the …

  • Acute Psychedelic Reactions, Post-Acute Changes in Dysfunctional Attitudes, and Psychedelic-Associated Changes in Wellbeing

    M Earleywine, Genevieve Falabella et al.ARTICLEJournal of Psychoactive Drugs2024

    Dysfunctional attitudes - a cornerstone to cognitive psychotherapy - vary with both psychological and pharmacological interventions. Post-acute changes in these cognitions appear to covary with the acute reactions to psychedelics that often precede improved outcomes. An examination of post-acute changes in dysfunctional attitudes could support targeting them in psychedelic-assisted therapy. Screened participants ( N = 400+) reported the acute, su…

  • Inhaled Dimethyltryptamine (DMT)

    Jamie E Parnes, M EarleywineARTICLEJournal of Psychoactive Drugs2024

    Despite increasing interest in psychedelics and their potential therapeutic effects, research on inhaled N,N -Dimethyltryptamine (DMT) remains limited. Inhaled DMT has a reputation for rapid, dramatic onset and a brief duration, but correlates of use frequency remain poorly understood. A sample recruited from relevant internet sites, including nearly 400 people who had inhaled DMT, reported substance use histories, motivations for use, DMT source…

  • Client treatment preferences in psychedelic-assisted therapy for depression in participants with depressive symptoms

    Open AccessAchille Bonito Oliva, M Earleywine et al.ARTICLEJournal of Psychedelic Studies2024

    Background and AimsResearch on psychedelic-assisted therapy (PAT), a promising treatment option for major depression, has not revealed if potential clients show preferences about the demographic characteristics of providers comparable to those common in other forms of psychotherapy. Previous work suggests that honoring comparable client preferences can enhance therapeutic outcomes. This study aims to investigate the importance ratings for a same-…

  • An examination of internal family systems interventions for trauma with implications for ethical psychedelic-assisted treatment

    Open AccessM Earleywine, Achille Bonito Oliva et al.ARTICLEJournal of Psychedelic Studies2024Citada por: 1

    Though several treatments effectively address the pervasive impact of trauma, they do not achieve complete symptom resolution for all clients, inspiring the search for alternatives. Internal Family Systems (IFS) therapy has grown popular, especially in informal psychedelic-assisted treatments (PAT). Compared to stereotypes of empirically validated, exposure-based treatments, IFS has novel facets with widespread appeal. The model encourages improv…

  • Psychedelic Experiences After Bereavement Improve Symptoms of Grief

    Francis Low, M EarleywineARTICLEJournal of Psychoactive Drugs2023

    Grief, a common reaction to loss, can frequently become problematic or impairing. Available treatments for prolonged grief disorder are promising but leave room for considerable improvement. Qualitative accounts of psychedelic experiences after bereavement reveal themes that parallel core components of prolonged grief disorder therapy. However, few studies have investigated the therapeutic potential of psychedelics for symptoms of grief. The pres…

  • Educational Materials and Image Induction Increase Treatment Credibility

    Francis Low, M EarleywineARTICLEJournal of Psychoactive Drugs2023

    Patient-perceived treatment credibility is linked to important outcome measures including symptom reduction, therapeutic alliance, patient satisfaction, and attrition rates. However, few studies have tested strategies to enhance treatment credibility. The present study investigates the effect of brief, written educational materials and the use of an image induction prime on perceptions of credibility for cognitive behavioral therapy and psilocybi…

  • Expectancies for Subjective and Antidepressant Effects in Psilocybin Users

    Open AccessM Earleywine, Maha N Mian et al.ARTICLEJournal of Humanistic Psychology2023Referencias: 74

    Expectancy effects for many psychoactive substances appear to play a role in consumption, problematic use, subjective responses to acute administration, and subsequent effects. Expectancies of psychedelics have received little attention in published research despite their reputation for creating dramatic changes in subjective state. Psilocybin-assisted treatment (PAT) improves depression, but details of associated expected effects remain incomple…

  • Caregiver Maltreatment Subtypes and Timing

    Open AccessKate L Senich, Elana B Gordis et al.ARTICLEJournal of Family Violence2023Referencias: 2

  • Reasonable expectations for replications of psychedelic-assisted therapy

    Open AccessM Earleywine, Philip Kamilar-BrittARTICLEJournal of Psychedelic Studies2023

    Psychedelic compounds hold promise for alleviating human suffering. Initial trials of psychedelic-assisted treatments have established feasibility and safety, generating calls for replications. Meanwhile, social and medical sciences have drawn criticism due to perceptions of replication failures and varying public trust in empiricism. Data suggest that researchers and the public frequently misunderstand some of the statistical issues associated w…

  • Savoring as an intervention for cannabis use

    Maha N Mian, M EarleywineARTICLEAddiction Research & Theory2022

    Although savoring appears protective against cannabis problems, researchers have yet to apply it to reduce cannabis-related harms. Study I surveyed a large (N = 557, Mage = 36.9, 50.1% Male, 73% White) sample who rated a hypothetical savoring intervention as feasible and acceptable; those who savored more reported fewer cannabis problems, less use, and less intoxication. Study II, a pilot experiment (N = 26, Mage = 18, 34.6% Male, 42% White), ran…

  • How Important Is a Guide Who Has Taken Psilocybin in Psilocybin-Assisted Therapy for Depression

    M Earleywine, Francis Low et al.ARTICLEJournal of Psychoactive Drugs2022

    Promising outcomes of Psilocybin-Assisted Therapy (PAT) for depression have generated concerted efforts to replicate, extend, and refine protocols to maximize efficacy. Psychotherapy research reveals that clients benefit most when important components of treatment align with their personal preferences. One open question related to PAT concerns the importance of the psilocybin experience of the guides (trained professionals present during acute ef…

  • Exploring the Credibility of Psilocybin-assisted Therapy and Cognitive-behavioral Therapy for Depression

    Brianna R Altman, M Earleywine et al.ARTICLEJournal of Psychoactive Drugs2022

    Depression treatments succeed with many but leave others unimproved, and they can generate concerns about side effects, time, and cost. Psilocybin has generated media attention and empirical support for antidepressant effects, but lay impressions of its effectiveness are unclear. Although perceptions of treatment credibility contribute to outcome, beliefs about the credibility of psilocybin-assisted therapy (PAT) among potential patients remain u…

  • Scoping Review of Experiential Measures from Psychedelic Research and Clinical Trials

    Zachary Herrmann, M Earleywine et al.ARTICLEJournal of Psychoactive Drugs2022

    Subjective responses to psychoactive drugs have served as intriguing windows into consciousness as well as useful predictors. Subjective reactions to psychedelic molecules are particularly interesting given how they covary with subsequent improvements associated with psychedelic-assisted treatments. Although links between subjective reactions and decreases in treatment-resistant clinical depression, end-of-life anxiety, and maladaptive consumptio…

  • Integration in Psychedelic-Assisted Treatments

    Open AccessM Earleywine, Francis Low et al.ARTICLEJournal of Humanistic Psychology2022Citada por: 5Referencias: 21

    Integration therapy, an integral part of psychedelic-assisted treatment, usually includes sessions devoted to making meaning of relevant psychedelic experiences after subjective effects have subsided. As the psychedelic renaissance continues, offers for this integration therapy have proliferated. In the present project, semi-structured interviews with 30 integration therapists focused on definitions of integration as well as challenges and concer…

  • A Semantic Scale Network analysis of the revised Mystical Experiences Questionnaire

    Open AccessM Earleywine, Francis Low et al.ARTICLEJournal of Psychedelic Studies2022Referencias: 60

    Background and aims Multiple laboratories have proposed measures of subjective effects of psychedelics as potential mediators of their therapeutic impact. Other work has identified individual differences that covary with subjective responses in informative ways. The range of potential measures of responses, traits, and outcomes is vast. Ideas for new measures are likely numerous. The field will progress efficiently if proposed new scales can add …

  • Mystical experiences without mysticism

    Open AccessBradley Armour Garb, M EarleywineARTICLEJournal of Psychedelic Studies2022Citada por: 1Referencias: 40

    Mystical experiences frequently precede decreases in human suffering or increased functioning. Therapies that include the ingestion of psychoactive substances in supportive environments often lead to improvements that correlate with the magnitude of the mystical experiences generated. A close look at these phenomena from a philosophy of science perspective might put empiricists in a quandary. Arguments with critics of the import of these mystical…

  • Replicating the Dimensional Structure of Cannabis Problems

    M Earleywine, Thomas F Denson et al.ARTICLESubstance Use & Misuse2021

    Objective: This study employed taxometric procedures to replicate a previous report of the dimensional structure of problems related to cannabis consumption. Method: Over 4,000 cannabis users completed an assessment of psychological, social, occupational, and physical harms (the Marijuana Problems Scale). Three taxometric procedures (MAMBAC, MAXEIG, and L-Mode) compared the current data to simulations with a base rate of problematic cannabis use …

  • Associations between Cannabis Use and Sexual Risk Behavior among Women under Community Supervision

    Melissa N Slavin, Karli R Hochstatter et al.ARTICLEInternational Journal of Sexual…2021

    OBJECTIVES: Cannabis use and sexual risk behavior have been found to co-occur, but more research on these associations is needed among criminal justice-involved women (i.e., courts, jails, or prisons). METHODS: Regression models examined past 90-day cannabis use on unprotected sex, multiple sexual partners, and STIs/HIV among 306 women under NYC community supervision, adjusting for alcohol, other illicit substances, and socio-demographics. RESULT…

  • Age-Related Differences in Cannabis Product Use

    Luna F Ueno, Maha N Mian et al.ARTICLEJournal of Psychoactive Drugs2021

    Cannabis use varies with age and gender, but less is known regarding specific product choices. Previous work suggests that older adults are inclined to stick to the more "classic" and familiar, while "novel" products are more likely to appeal to younger populations. We examined cross-sectional, retrospective data to determine whether the type of cannabis products used varied according to participant age ( N = 1406, 71.3% female). The extensive li…

  • Cognitive Behavioral Therapy, Ketamine, and Combination Treatment for Depression

    M Earleywine, Brianna R Altman et al.ARTICLEJournal of Psychoactive Drugs2021

    Ketamine, a novel treatment for depression, has generated considerable interest and research. Few experiments address lay impressions of the credibility of ketamine treatment relative to another popular intervention for depression, CBT. Over 500 participants with depressive symptoms read descriptions of CBT, ketamine, and a treatment that combined the two. Descriptions included pros and cons of each approach. Participants found the combination tr…